Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats

BACKGROUND: A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) has been developed to provide broad spectrum parasite protection for cats. The effectiveness and safety of this product against ticks and fleas was assessed in a randomized, controlled, 12...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohdich, Nadja, Zschiesche, Eva, Wolf, Oliver, Loehlein, Wolfgang, Pobel, Thierry, Gil, Maria José, Roepke, Rainer K. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240940/
https://www.ncbi.nlm.nih.gov/pubmed/30454052
http://dx.doi.org/10.1186/s13071-018-3175-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240940/
https://www.ncbi.nlm.nih.gov/pubmed/30454052
http://dx.doi.org/10.1186/s13071-018-3175-z

Ejemplares similares